Psych210
© Cengage Learning 2016 © Cengage Learning 2016
Psychopharmacology
Chapter Four
© Cengage Learning 2016
• Neurotransmitters – Participate in directed synapses by acting on
neurons in their own immediate vicinity • Neuromodulators and neurohormones
– Participate in nondirected synapses by acting on more distant neurons
– Neuromodulators communicate with target diffuse away from the point of release
– Neurohormones travel in the blood supply to reach their final targets
Neurotransmitters, Neuromodulators, and Neurohormones
© Cengage Learning 2016
Neuromodulators and Neurohormones
© Cengage Learning 2016
• Substances released by one cell that produce a reaction in a target cell
• The substance: – Must be present within a presynaptic cell. – Is released in response to presynaptic
depolarization – Interacts with specific receptors on a
postsynaptic cell
Identifying Neurochemicals
© Cengage Learning 2016
Types of Neurochemicals
© Cengage Learning 2016
Features of Small-Molecules and Neuropeptides
© Cengage Learning 2016
• Produced in cholinergic neurons • Two receptor types:
– Nicotinic receptors – Muscarinic receptors
Small-Molecule Neurochemicals: Acetylcholine
© Cengage Learning 2016
The Distribution of Cholinergic Systems in the Brain
© Cengage Learning 2016
• Catecholamines – Dopamine, norepinephrine, epinephrine – Synthesized from tyrosine
• Indoleamines – Serotonin, melatonin – Serotonin is synthesized from tryptophan
Small-Molecule Neurochemicals: Monoamines
© Cengage Learning 2016
Catecholamines Share a Common Synthesis Pathway
© Cengage Learning 2016
• Dopaminergic neurons in the midbrain form connections with other neurons
• Dopamine activity is associated with motivated behavior and reward processing
Dopaminergic Systems in the Brain
© Cengage Learning 2016
Dopaminergic Systems in the Brain (cont’d.)
© Cengage Learning 2016
• Norepinephrine – Noradrenergic neurons – Increases arousal and vigilance – Primary neurotransmitter in the sympathetic
nervous system • Epinephrine
– Adrenergic neurons – Regulation of eating, blood pressure
Noradrenergic Systems in the Brain
© Cengage Learning 2016
Noradrenergic Systems in the Brain (cont’d.)
© Cengage Learning 2016
• Synthesized from tryptophan • Regulates mood, sleep, and appetite
Indoleamines: Serotonin
© Cengage Learning 2016
Serotonergic Pathways in the Brain
© Cengage Learning 2016
• Synthesized from histidine • Associated with wakefulness
Histamine
© Cengage Learning 2016
• Major excitatory neurotransmitter in the CNS
• Subtypes of glutamate receptors: NMDA, AMPA, and kainate
Amino Acid Messengers: Glutamate
© Cengage Learning 2016
• Major inhibitory neurochemical in the CNS • Synthesized from glutamate • GABAA and GABAB receptors
– GABAA receptors interact with psychoactive drugs
Amino Acid Messengers: GABA
© Cengage Learning 2016
The GABAA Receptor Interacts with Several Drugs
© Cengage Learning 2016
• Major inhibitory neurochemical in spinal cord interneurons
• Excitatory function with glutamate at NMDA receptors
• Synthesized from serine
Amino Acid Messengers: Glycine
© Cengage Learning 2016
• Act in the CNS and in connections between autonomic neurons and the vas deferens, bladder, heart, and gut – ATP is associated with pain perception and
sleep-waking cycles – Adenosine inhibits the release of many
neurochemicals
ATP and Adenosine
© Cengage Learning 2016
• Substance P (pain perception) • Endorphins act on same receptors as
opioids and heroin • Insulin and cholecystokinin function in
digestion and as neuromodulators and neurohormones
• Oxytocin and vasopressin act as neuromodulators and neurohormones
Neuropeptides
© Cengage Learning 2016
Distribution of Endorphin Receptors in the Human Brain
© Cengage Learning 2016
• Diffuse through membranes and interact with intracellular receptors
• Transmits information from the postsynaptic to the presynaptic neurons
• Nitric oxide (NO) – Neural communication, maintenance of blood
pressure, erection (target of Viagra)
Gasotransmitters
© Cengage Learning 2016
• Agonists enhance the activity of a neurotransmitter
• Antagonists reduce the activity of a neurotransmitter
Drug Actions at the Synapse
© Cengage Learning 2016
• Neurochemical production – Manipulating the synthesis of a
neurotransmitter may affect the amount available for release
• Neurochemical storage – Interfering with the storage of a
neurotransmitters in vesicles within a neuron • Neurochemical release
– Can be modified in response to the arrival of an action potential by drugs
Mechanisms of Drug Actions at the Synapse
© Cengage Learning 2016
• Mimic the action of a neurotransmitter at the site
• Block the synaptic activity by occupying a binding site
• Influence the activity of the receptor
Mechanisms of Drug Actions at the Synapse: Receptor Effects
© Cengage Learning 2016
Drug Interactions at the Cholinergic Synapse
© Cengage Learning 2016
Drug Interactions at the Dopaminergic Synapse
© Cengage Learning 2016
Drug Interactions at the Serotonergic Synapse
© Cengage Learning 2016
• Reuptake effects – Cocaine, amphetamine, and Ritalin inhibit
dopamine reuptake – SSRIs (e.g., Prozac) inhibit serotonin
reuptake • Enzymatic degradation
– Organophosphates interfere with AChE • Deactivation of neurotransmitters
Reuptake Effects and Enzymatic Degradation
© Cengage Learning 2016
• Administration of drugs – Method of administration leads to different
effects on nervous system; blood-brain barrier • Individual differences
– Drug effects influenced by body weight, gender, and genetics
• Placebo effects – User expectations influence drug effects – Double-blind experiment
Basic Principles of Drug Effects
© Cengage Learning 2016
Concentration of a Drug in the Blood Supply Depends on the Method of Administration
© Cengage Learning 2016
• Tolerance – Lessened effects as a result of repeated
administration • Withdrawal
– Occurs when substance use is discontinued; opposite of the effects caused by the discontinued drug
• Addiction – Compulsive need to use the drug repeatedly
despite harm to the user
Tolerance, Withdrawal, and Addiction
© Cengage Learning 2016
Vaccinations Against Drugs of Abuse
© Cengage Learning 2016
• Increase alertness and mobility – Caffeine – adenosine antagonist – Nicotine – nicotinic cholinergic receptor
agonist – Cocaine – dopamine reuptake inhibitor – Amphetamine – stimulates release and
inhibits reuptake of dopamine/norepinephrine – Ecstasy (MDMA) – stimulates release of
serotonin and oxytocin; toxic to serotonergic neurons
Effects of Psychoactive Drugs: Stimulants
© Cengage Learning 2016
Caffeine Content of Common Products
© Cengage Learning 2016
Caffeine Content of Common Products (cont’d.)
© Cengage Learning 2016
Health Consequences of Methamphetamine Abuse
© Cengage Learning 2016
Historical Use of Cocaine
© Cengage Learning 2016
Ecstasy Damages Serotonergic Neurons
© Cengage Learning 2016
• Interact with endorphin receptors – Pain relief, relaxation, sense of euphoria
• Opiates – Derived from sap of opium poppy – Morphine, codeine – Heroin
• Synthetic opiate • Derived from morphine
Opioids
© Cengage Learning 2016
• Active ingredient THC is an endogenous cannabinoid receptor agonist
• Cannabinoid receptors are in the hippocampus and prefrontal cortex
• Effects: mild euphoria, perceptual distortion, hallucination, and depression
Marijuana (Cannabis)
© Cengage Learning 2016
Cannabis and the Risk of Psychosis
© Cengage Learning 2016
• Serotonergic agonist • No known medicinal value • Hallucinogens • Use results in tolerance, but not addiction
or withdrawal • Flashbacks with extended use
LSD
© Cengage Learning 2016
• GABAA receptor agonist • Stimulates dopaminergic reward pathways • Rapid tolerance • Damaging effects on health
Alcohol
© Cengage Learning 2016
Alcohol and Mortality